will compounded tirzepatide be banned Is Being Banned? Legal Status 2024 The FDA's Decision to Ban

Diabetes, Obesity and Metabolism, 25(1), 1-10

Mounjaro is approved for diabetes, while Zepbound is approved for weight loss

Tirzepatide doses range higher, up to 15mg weekly, which may contribute to its greater average effect

The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations